161 related articles for article (PubMed ID: 36181835)
21. Fisetin Protects Against Hepatic Steatosis Through Regulation of the Sirt1/AMPK and Fatty Acid β-Oxidation Signaling Pathway in High-Fat Diet-Induced Obese Mice.
Liou CJ; Wei CH; Chen YL; Cheng CY; Wang CL; Huang WC
Cell Physiol Biochem; 2018; 49(5):1870-1884. PubMed ID: 30235452
[TBL] [Abstract][Full Text] [Related]
22. Disruption of hepatic small heterodimer partner induces dissociation of steatosis and inflammation in experimental nonalcoholic steatohepatitis.
Magee N; Zou A; Ghosh P; Ahamed F; Delker D; Zhang Y
J Biol Chem; 2020 Jan; 295(4):994-1008. PubMed ID: 31831621
[TBL] [Abstract][Full Text] [Related]
23. APOC3 Protein Is Not a Predisposing Factor for Fat-induced Nonalcoholic Fatty Liver Disease in Mice.
Cheng X; Yamauchi J; Lee S; Zhang T; Gong Z; Muzumdar R; Qu S; Dong HH
J Biol Chem; 2017 Mar; 292(9):3692-3705. PubMed ID: 28115523
[TBL] [Abstract][Full Text] [Related]
24. Fas cell surface death receptor controls hepatic lipid metabolism by regulating mitochondrial function.
Item F; Wueest S; Lemos V; Stein S; Lucchini FC; Denzler R; Fisser MC; Challa TD; Pirinen E; Kim Y; Hemmi S; Gulbins E; Gross A; O'Reilly LA; Stoffel M; Auwerx J; Konrad D
Nat Commun; 2017 Sep; 8(1):480. PubMed ID: 28883393
[TBL] [Abstract][Full Text] [Related]
25. Antrodia cinnamomea and its compound dehydroeburicoic acid attenuate nonalcoholic fatty liver disease by upregulating ALDH2 activity.
Cao YN; Yue SS; Wang AY; Xu L; Hu YT; Qiao X; Wu TY; Ye M; Wu YC; Qi R
J Ethnopharmacol; 2022 Jun; 292():115146. PubMed ID: 35304272
[TBL] [Abstract][Full Text] [Related]
26. SphK1 mediates hepatic inflammation in a mouse model of NASH induced by high saturated fat feeding and initiates proinflammatory signaling in hepatocytes.
Geng T; Sutter A; Harland MD; Law BA; Ross JS; Lewin D; Palanisamy A; Russo SB; Chavin KD; Cowart LA
J Lipid Res; 2015 Dec; 56(12):2359-71. PubMed ID: 26482537
[TBL] [Abstract][Full Text] [Related]
27. Hepatocyte-Specific Disruption of CD36 Attenuates Fatty Liver and Improves Insulin Sensitivity in HFD-Fed Mice.
Wilson CG; Tran JL; Erion DM; Vera NB; Febbraio M; Weiss EJ
Endocrinology; 2016 Feb; 157(2):570-85. PubMed ID: 26650570
[TBL] [Abstract][Full Text] [Related]
28. Disruption of adenosine 2A receptor exacerbates NAFLD through increasing inflammatory responses and SREBP1c activity.
Cai Y; Li H; Liu M; Pei Y; Zheng J; Zhou J; Luo X; Huang W; Ma L; Yang Q; Guo S; Xiao X; Li Q; Zeng T; Meng F; Francis H; Glaser S; Chen L; Huo Y; Alpini G; Wu C
Hepatology; 2018 Jul; 68(1):48-61. PubMed ID: 29315766
[TBL] [Abstract][Full Text] [Related]
29. Vitamin D receptor targets hepatocyte nuclear factor 4α and mediates protective effects of vitamin D in nonalcoholic fatty liver disease.
Zhang H; Shen Z; Lin Y; Zhang J; Zhang Y; Liu P; Zeng H; Yu M; Chen X; Ning L; Mao X; Cen L; Yu C; Xu C
J Biol Chem; 2020 Mar; 295(12):3891-3905. PubMed ID: 32051143
[TBL] [Abstract][Full Text] [Related]
30. Hepatocyte Smoothened Activity Controls Susceptibility to Insulin Resistance and Nonalcoholic Fatty Liver Disease.
Chen T; Dalton G; Oh SH; Maeso-Diaz R; Du K; Meyers RA; Guy C; Abdelmalek MF; Henao R; Guarnieri P; Pullen SS; Gregory S; Locker J; Brown JM; Diehl AM
Cell Mol Gastroenterol Hepatol; 2023; 15(4):949-970. PubMed ID: 36535507
[TBL] [Abstract][Full Text] [Related]
31. Impact of exenatide on mitochondrial lipid metabolism in mice with nonalcoholic steatohepatitis.
Kalavalapalli S; Bril F; Guingab J; Vergara A; Garrett TJ; Sunny NE; Cusi K
J Endocrinol; 2019 Jun; 241(3):293-305. PubMed ID: 31082799
[TBL] [Abstract][Full Text] [Related]
32. The tetraspanin transmembrane protein CD53 mediates dyslipidemia and integrates inflammatory and metabolic signaling in hepatocytes.
Higgins CB; Adams JA; Ward MH; Greenberg ZJ; Milewska M; Sun J; Zhang Y; Chiquetto Paracatu L; Dong Q; Ballentine S; Li W; Wandzik I; Schuettpelz LG; DeBosch BJ
J Biol Chem; 2023 Feb; 299(2):102835. PubMed ID: 36581203
[TBL] [Abstract][Full Text] [Related]
33. The American lifestyle-induced obesity syndrome diet in male and female rodents recapitulates the clinical and transcriptomic features of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Harris SE; Poolman TM; Arvaniti A; Cox RD; Gathercole LL; Tomlinson JW
Am J Physiol Gastrointest Liver Physiol; 2020 Sep; 319(3):G345-G360. PubMed ID: 32755310
[TBL] [Abstract][Full Text] [Related]
34. Vitamin D Receptor Activation in Liver Macrophages Ameliorates Hepatic Inflammation, Steatosis, and Insulin Resistance in Mice.
Dong B; Zhou Y; Wang W; Scott J; Kim K; Sun Z; Guo Q; Lu Y; Gonzales NM; Wu H; Hartig SM; York RB; Yang F; Moore DD
Hepatology; 2020 May; 71(5):1559-1574. PubMed ID: 31506976
[TBL] [Abstract][Full Text] [Related]
35. Ascorbic acid inhibits visceral obesity and nonalcoholic fatty liver disease by activating peroxisome proliferator-activated receptor α in high-fat-diet-fed C57BL/6J mice.
Lee H; Ahn J; Shin SS; Yoon M
Int J Obes (Lond); 2019 Aug; 43(8):1620-1630. PubMed ID: 30283077
[TBL] [Abstract][Full Text] [Related]
36. RORα contributes to the maintenance of genome ploidy in the liver of mice with diet-induced nonalcoholic steatohepatitis.
Kim JY; Yang IS; Kim HJ; Yoon JY; Han YH; Seong JK; Lee MO
Am J Physiol Endocrinol Metab; 2022 Feb; 322(2):E118-E131. PubMed ID: 34894722
[TBL] [Abstract][Full Text] [Related]
37. Nrf2 deletion causes "benign" simple steatosis to develop into nonalcoholic steatohepatitis in mice fed a high-fat diet.
Wang C; Cui Y; Li C; Zhang Y; Xu S; Li X; Li H; Zhang X
Lipids Health Dis; 2013 Nov; 12():165. PubMed ID: 24188280
[TBL] [Abstract][Full Text] [Related]
38. Suppression of hepatic ChREBP⍺-CYP2C50 axis-driven fatty acid oxidation sensitizes mice to diet-induced MASLD/MASH.
Zhang D; Zhao Y; Zhang G; Lank D; Cooke S; Wang S; Nuotio-Antar A; Tong X; Yin L
Mol Metab; 2024 Jul; 85():101957. PubMed ID: 38740087
[TBL] [Abstract][Full Text] [Related]
39. Adipose type I interferon signalling protects against metabolic dysfunction.
Wieser V; Adolph TE; Grander C; Grabherr F; Enrich B; Moser P; Moschen AR; Kaser S; Tilg H
Gut; 2018 Jan; 67(1):157-165. PubMed ID: 28011892
[TBL] [Abstract][Full Text] [Related]
40. Lipid-Induced Signaling Causes Release of Inflammatory Extracellular Vesicles From Hepatocytes.
Hirsova P; Ibrahim SH; Krishnan A; Verma VK; Bronk SF; Werneburg NW; Charlton MR; Shah VH; Malhi H; Gores GJ
Gastroenterology; 2016 Apr; 150(4):956-67. PubMed ID: 26764184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
